238 related articles for article (PubMed ID: 22203734)
1. DNA methyltransferase inhibitor, zebularine, delays tumor growth and induces apoptosis in a genetically engineered mouse model of breast cancer.
Chen M; Shabashvili D; Nawab A; Yang SX; Dyer LM; Brown KD; Hollingshead M; Hunter KW; Kaye FJ; Hochwald SN; Marquez VE; Steeg P; Zajac-Kaye M
Mol Cancer Ther; 2012 Feb; 11(2):370-82. PubMed ID: 22203734
[TBL] [Abstract][Full Text] [Related]
2. Zebularine enhances apoptosis of human osteosarcoma cells by suppressing methylation of ARHI.
Ye K; Wang S; Wang J; Han H; Ma B; Yang Y
Cancer Sci; 2016 Dec; 107(12):1851-1857. PubMed ID: 27685841
[TBL] [Abstract][Full Text] [Related]
3. Global expression profiling identifies signatures of tumor virulence in MMTV-PyMT-transgenic mice: correlation to human disease.
Qiu TH; Chandramouli GV; Hunter KW; Alkharouf NW; Green JE; Liu ET
Cancer Res; 2004 Sep; 64(17):5973-81. PubMed ID: 15342376
[TBL] [Abstract][Full Text] [Related]
4. Enhancement of in vitro and in vivo tumor cell radiosensitivity by the DNA methylation inhibitor zebularine.
Dote H; Cerna D; Burgan WE; Carter DJ; Cerra MA; Hollingshead MG; Camphausen K; Tofilon PJ
Clin Cancer Res; 2005 Jun; 11(12):4571-9. PubMed ID: 15958643
[TBL] [Abstract][Full Text] [Related]
5. DNA methyltransferase inhibitor zebularine induces human cholangiocarcinoma cell death through alteration of DNA methylation status.
Nakamura K; Nakabayashi K; Htet Aung K; Aizawa K; Hori N; Yamauchi J; Hata K; Tanoue A
PLoS One; 2015; 10(3):e0120545. PubMed ID: 25799509
[TBL] [Abstract][Full Text] [Related]
6. Effects of a novel DNA methyltransferase inhibitor zebularine on human breast cancer cells.
Billam M; Sobolewski MD; Davidson NE
Breast Cancer Res Treat; 2010 Apr; 120(3):581-92. PubMed ID: 19459041
[TBL] [Abstract][Full Text] [Related]
7. Zebularine significantly sensitises MEC1 cells to external irradiation and radiopharmaceutical therapy when administered sequentially in vitro.
Bryan JN; Kumar SR; Jia F; Balkin ER; Lewis MR
Cell Biol Int; 2014 Feb; 38(2):187-97. PubMed ID: 24323360
[TBL] [Abstract][Full Text] [Related]
8. DNA methyltransferase inhibitor zebularine inhibits human hepatic carcinoma cells proliferation and induces apoptosis.
Nakamura K; Aizawa K; Nakabayashi K; Kato N; Yamauchi J; Hata K; Tanoue A
PLoS One; 2013; 8(1):e54036. PubMed ID: 23320119
[TBL] [Abstract][Full Text] [Related]
9. Effect of Zebularine in Comparison to and in Combination with Trichostatin A on CIP/KIP Family (p21Cip1/Waf1/Sdi1, p27Kip1, and p57Kip2), DNMTs (DNMT1, DNMT3a, and DNMT3b), Class I HDACs (HDACs 1, 2, 3) and Class II HDACs (HDACs 4, 5, 6) Gene Expression, Cell Growth Inhibition and Apoptosis Induction in Colon Cancer LS 174T Cell Line.
Sanaei M; Kavoosi F
Asian Pac J Cancer Prev; 2020 Jul; 21(7):2131-2139. PubMed ID: 32711442
[TBL] [Abstract][Full Text] [Related]
10. Effects of a novel DNA methyltransferase inhibitor Zebularine on human lens epithelial cells.
Zhou P; Lu Y; Sun XH
Mol Vis; 2012; 18():22-8. PubMed ID: 22259221
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of DNA methylation and reactivation of silenced genes by zebularine.
Cheng JC; Matsen CB; Gonzales FA; Ye W; Greer S; Marquez VE; Jones PA; Selker EU
J Natl Cancer Inst; 2003 Mar; 95(5):399-409. PubMed ID: 12618505
[TBL] [Abstract][Full Text] [Related]
12. Long-term epigenetic therapy with oral zebularine has minimal side effects and prevents intestinal tumors in mice.
Yoo CB; Chuang JC; Byun HM; Egger G; Yang AS; Dubeau L; Long T; Laird PW; Marquez VE; Jones PA
Cancer Prev Res (Phila); 2008 Sep; 1(4):233-40. PubMed ID: 19138966
[TBL] [Abstract][Full Text] [Related]
13. Zebularine upregulates expression of CYP genes through inhibition of DNMT1 and PKR in HepG2 cells.
Nakamura K; Aizawa K; Aung KH; Yamauchi J; Tanoue A
Sci Rep; 2017 Jan; 7():41093. PubMed ID: 28112215
[TBL] [Abstract][Full Text] [Related]
14. The DNA methyltransferase inhibitor zebularine induces mitochondria-mediated apoptosis in gastric cancer cells in vitro and in vivo.
Tan W; Zhou W; Yu HG; Luo HS; Shen L
Biochem Biophys Res Commun; 2013 Jan; 430(1):250-5. PubMed ID: 23167995
[TBL] [Abstract][Full Text] [Related]
15. Adiponectin deficiency limits tumor vascularization in the MMTV-PyV-mT mouse model of mammary cancer.
Denzel MS; Hebbard LW; Shostak G; Shapiro L; Cardiff RD; Ranscht B
Clin Cancer Res; 2009 May; 15(10):3256-64. PubMed ID: 19447866
[TBL] [Abstract][Full Text] [Related]
16. Zebularine inhibits human acute myeloid leukemia cell growth in vitro in association with p15INK4B demethylation and reexpression.
Scott SA; Lakshimikuttysamma A; Sheridan DP; Sanche SE; Geyer CR; DeCoteau JF
Exp Hematol; 2007 Feb; 35(2):263-73. PubMed ID: 17258075
[TBL] [Abstract][Full Text] [Related]
17. Proangiogenic contribution of adiponectin toward mammary tumor growth in vivo.
Landskroner-Eiger S; Qian B; Muise ES; Nawrocki AR; Berger JP; Fine EJ; Koba W; Deng Y; Pollard JW; Scherer PE
Clin Cancer Res; 2009 May; 15(10):3265-76. PubMed ID: 19447867
[TBL] [Abstract][Full Text] [Related]
18. Bisected, complex N-glycans and galectins in mouse mammary tumor progression and human breast cancer.
Miwa HE; Koba WR; Fine EJ; Giricz O; Kenny PA; Stanley P
Glycobiology; 2013 Dec; 23(12):1477-90. PubMed ID: 24037315
[TBL] [Abstract][Full Text] [Related]
19. Continuous zebularine treatment effectively sustains demethylation in human bladder cancer cells.
Cheng JC; Weisenberger DJ; Gonzales FA; Liang G; Xu GL; Hu YG; Marquez VE; Jones PA
Mol Cell Biol; 2004 Feb; 24(3):1270-8. PubMed ID: 14729971
[TBL] [Abstract][Full Text] [Related]
20. Integrated miRNA and mRNA expression profiling of mouse mammary tumor models identifies miRNA signatures associated with mammary tumor lineage.
Zhu M; Yi M; Kim CH; Deng C; Li Y; Medina D; Stephens RM; Green JE
Genome Biol; 2011 Aug; 12(8):R77. PubMed ID: 21846369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
